[HT-04] Toward the eary diagnosis and treatment of Progressive Supranuclear Palsy

[HT-04-1] Clinical Diagnosis of Progressive supranuclear palsy - The Movement Disorder Society Criteria

^○Günter Höglinger^1,2 (1.German Center for Neurodegenerative Diseases Munich, Germany, 2.Technical University Munich, Germany)

Chair | Dept. of Translational Neurodegeneration
German Center for Neurodegenerative Diseases (DZNE) Munich
Technical University Munich (TUM)
[e-mail]

Degrees
• 2011 Full Professorship, Technical University Munich, Germany
• 2000-2007 PD, Habilitation, University of Marburg, Germany
• 1992-2000 MD, Universities of Regensburg, Würzburg and Marburg, Germany
• 1991-1993 BSc, Physics, University of Regensburg, Germany

Major appointments
• since 2017 Head of the Interdisciplinary Clinical Trial Unit, DZNE Munich
• since 2011 Chair for Translational Neurodegeneration, TUM and DZNE Munich
• since 2011 Senior Consultant, Dept. for Neurology, TUM, Munich
• 2011 Deputy Director, Dept. of Neurology, Marburg University
• 2009-20010 Managing Senior Consultant, Dept. of Neurology, Marburg University


Activities in the Scientific Community / Professional Memberships
• since 2017 President elect, German Parkinson Association (DPG)
• since 2015 Member of SABs of AbbVie, Asceneuron, Biogen, Roche, Sanofi, UCB
• since 2012 Chair, International Movement Disorders Society-endorsed PSP Study Group

Honors and Awards
• 2017 Dingebauer Prize for research in atypical Parkinson syndromes, German Society for Neurology
• 2011-2016 Heisenberg Professorship, excellence program, German Research Council
• 2009 First Price for „Innovative therapeutic strategies for neurodegenerative disorders“
Dr. Walter und Luise Freundlich-Foundation
• 1994-1999 Student Scholarship, Hanns Seidel Foundation